Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Accept

;

Press Releases

7/21/2020

Aachen, Germany & Morristown, N.J. – 21 July 2020 – Grünenthal announced today that its U.S. subsidiary Averitas Pharma, Inc. received U.S. Food and Drug Administration (FDA) approval for QUTENZA® (capsaicin) 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults.2 QUTENZA® is a topical, non-systemic, non-opioid pain treatment delivered in the form of a patch and is the first and only treatment of its kind to deliver prescription strength capsaicin directly into the skin.

6/16/2020

Aachen, Deutschland, 16. Juni 2020 – Grünenthal, ein weltweit führendes Unternehmen im Bereich der Schmerzbehandlung und verwandten Erkrankungen, durfte sich am 15. Juni 2020 über eine besondere Auszeichnung freuen: Bereits zum vierten Mal wurde das Aachener Unternehmen mit dem renommierten Zertifikat zum audit berufundfamilie ausgezeichnet – diesmal jedoch sogar mit dem Zusatz „mit dauerhaftem Charakter“. Damit wird das Zertifikat, das als Qualitätssiegel für eine strategisch angelegte familien- und lebensphasenbewusste Personalpolitik gilt, nicht mehr nur für einen bestimmten Zeitraum, sondern dauerhaft vergeben. Zu den Gratulant*innen zählte unter anderem Bundesfamilienministerin Dr. Franziska Giffey, die die Schirmherrschaft übernommen hat.

2/4/2020

Aachen, Germany, 04 February 2020 – Grünenthal, a global leader in pain management and related diseases, has announced it will now include electric and hybrid engines in the fleet of company cars for managers at its site in Aachen, Germany. The decision is part of the company’s ongoing commitment to promoting sustainability by reducing the environmental footprint of its operations. And it also marks the latest step forward in its long tradition of investing in future-facing technologies.

Fabia Kehren, Head External Communications and Editorial Management

Fabia Kehren

Head External Communications and Editorial Management


Grünenthal GmbH

52099 Aachen


Phone +49 241 569-1616

E-Mail Fabia.Kehren@grunenthal.com